Pfizer is recalling batches of its Xalatan eye-drop product, used to treat glaucoma, after discovering fakes in the marketplace with valid batch numbers.
The company said that the falsified product “was being distributed in the legitimate supply chain in the Nigerian market”. The fakes with batch number W67369 have an expiry date of 10/2020, while the AK4753 batch has an expiry date of 10/2021.
Source : www.securingindustry.com
Within the space of two days, Kaolack customs officers stopped two cars full of illicit medicines. The seized products included: bottles of paracetamol syrup, paracetamol in tablet form, and aphrodisiacs (powerga 100, puregrey 100). The products are thought to be worth CFA 50M.
Source : www.dakaractu.com
Frank Arabi, a medical student at Muhimbili University of Health and Allied Sciences, co-founded PharmLinks software to link pharmaceutical suppliers and wholesalers with retailers in Tanzania. The platform aims to improve medicine tracking and distribution. PharmLinks was launched in 2018 and is still in the pilot phase: 35 pharmacists can now freely log onto the website and search medical products they want in their shops. The system directs them to wholesale suppliers and stores which have undergone safety checks. The pharmacists can then pay for the products and delivery online.
Source : www.globalvoices.org
A clandestine factory manufacturing blisters, tablets and boxes for fake medicines in Chorrillos has been sealed. The traffickers had set up numerous machines to manufacture the fake medicines, which were sold online. The factory was located in a regular private home which was also used as a laboratory and medicines storage depot.
Source : www.m.panamericana.pe
The interim parliament president has introduced Senate Resolution 82 which directs the Senate Health and Demography committee to conduct an inquiry, in aid of legislation, on the proliferation of falsified medicines. The request follows the 2019 United Nations Office on Drugs and Crime report which notes that the country had the highest incidence of “falsified medicines” in South East Asia. The investigation may lead to amendments to current legislation.
Source : www.manilatimes.net